IndiaOne Finance - Company Dashboard

Governance Classic Home

Coral Laboratories LtdPharmaceuticalsINE683E01017

Valuation

Market Cap₹203.66 Cr

TTM PE10.60x

Forward PE11.41x

PEG0.27

Book Value—

P/B—

TTM EPS₹53.76

Fwd EPS₹49.96

TTM Revenue₹96.70 Cr

TTM PAT₹19.21 Cr

TTM EBITDA₹18.51 Cr

TTM EBIT₹16.17 Cr

Last Qtr PAT₹5.22 Cr

Last Qtr EBITDA₹5.48 Cr

Last Qtr EBIT₹4.82 Cr

Profitability

ROE—

ROCE—

TTM NPM19.87%

TTM EBITDA %19.14%

Curr OPM18.19%

Last OPM19.73%

Curr NPM—

Last NPM—

Curr EPS₹15.08

Last EPS₹14.62

Balance sheet

Equity—

Reserve—

Total Debt₹0.00 Cr

D/E—

Interest %0.56%

Curr Interest₹0.03 Cr

Price / range

Close₹570.05

vs 52W High-16.05%

vs 52W Low+58.35%

MA50—

MA200—

Returns

1D-1.44%

1W-2.56%

1M-10.02%

3M+14.01%

6M+33.42%

1Y+6.56%

2Y-37.26%

3Y+102.58%

5Y+43.19%

Diwali+29.06%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	29.62+57.4%	26.48	21.56	19.04	18.82	85.90
Other Income	2.15	2.65	2.49	2.71	2.05	9.90
Total Income	31.77+52.2%	29.13	24.06	21.74	20.87	95.80
Interest	0.03	0.01	0	0.10	0.06	0.17
Expenditure	-24.83-45.2%	-20.83	-20.36	-14.65	-17.10	-72.99
PBDT	0	0	0	0	0	0
EBITDA	5.48+145.7%	6.20	1.89	4.94	2.23	15.22
Depreciation	-0.66	-0.54	-0.69	-0.45	-0.45	-2.14
EBIT	4.82+170.8%	5.66	1.20	4.49	1.78	13.08
PBT	6.94+86.6%	8.29	3.70	7.42	3.72	23.12
Tax	-1.56	-3.06	-0.92	-1.60	-1.10	-6.73
Equity	0	0	0	0	0	0
OPM	23.44	31.30	17.14	38.95	19.76	24.00
Net Profit	5.39+110.5%	5.22	2.78	5.82	2.56	16.38
NPM	18.19	19.73	12.87	30.58	13.62	17.00
EPS	15.08	14.62	7.77	16.29	0	45.85

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	85.90-25.3%	115.01+37.5%	83.66+7.1%	78.12+3.3%	75.61-21.7%	96.57
Other Income	9.90	9.11	6.63	6.90	4.81	3.77
Total Income	95.80-22.8%	124.11+37.5%	90.29+6.2%	85.01+5.7%	80.43-19.8%	100.34
Expenditure	-72.99+19.6%	-90.80-30.8%	-69.40+9.7%	-76.83-10.5%	-69.53+16.0%	-82.74
Interest	-0.17	-0.10	0	-0.34	-0.14	-0.04
PBDT	0	0	0	0	0	0
EBITDA	15.22-42.2%	26.32+62.1%	16.24+326.2%	3.81-53.6%	8.21-48.2%	15.85
Depreciation	-2.14	-2.01	-1.98	-2.18	-1.99	-1.98
EBIT	13.08-46.2%	24.31+70.5%	14.26+774.8%	1.63-73.8%	6.22-55.2%	13.87
PBT	23.12-28.8%	32.47+56.6%	20.73+151.9%	8.23-30.6%	11.86-32.7%	17.61
Tax	-6.73	-8.30	-4.94	-1.78	-2.81	-4.06
Equity	0	0	0	0	0	0
OPM (%)	24.00	26.00	23.00	10.00	15.00	18.00
Net Profit	16.38-32.2%	24.16+53.0%	15.79+144.8%	6.45-28.7%	9.05-33.3%	13.56
NPM (%)	17.00	19.00	17.00	8.00	11.00	14.00
EPS (Rs)	45.85-32.2%	67.61+53.0%	44.19+145.0%	18.04-28.8%	25.32-33.3%	37.94
CEPS	45.85	67.61	44.19	18.04	0	0

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1.5	19 Sep 2025
2024	Final Dividend	2	20 Sep 2024
2019	Final Dividend	2	19 Sep 2019
2018	Final Dividend	2	18 Sep 2018
2017	Final Dividend	5	11 Sep 2017
2016	Final Dividend	3	16 Sep 2016
2015	Final Dividend	2.5	08 Sep 2015
2014	Final Dividend	2	16 Sep 2014
2013	Final Dividend	1.5	18 Sep 2013
2012	Final Dividend	1.5	17 Sep 2012
2011	Final Dividend	1.5	19 Sep 2011
2010	Final Dividend	1.5	17 Sep 2010
2009	Final Dividend	1.2	17 Sep 2009
2008	Final Dividend	1	19 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split